The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies.

In the EGFR/RD model, similar effects were observed on tumor growth and T cell recruitment but did not reach statistical significance ( Fig. 5D ), which may be attributed to different T cell mode activity that will require further studies.

also in 111,027 other papers